Orphazyme
Copenhagen · Founded 2009
About Orphazyme
Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jååttela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse). Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
Company Facts
- Founded: 2009
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $262.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2020)
- Ticker: cph:ORPHA
- Website: orphazyme.com
- Phone: 45 70 70 29 80
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/orphazyme-186177 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.